Ryan Hicks
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
69
Citations
1,861
Est. group size
—
Recurring co-author estimate
Active years
52
Publishing since 1975
Ryan Hicks works on stem cell biology and disease modeling, using human induced pluripotent stem cells (iPSCs), gene editing tools like CRISPR, and lab-grown tissue models (such as organs-on-chips) to study conditions like vascular malformations, kidney disease, cardiac disorders, and cancer. Much of the work involves building cell-based models that mimic human tissues to understand disease mechanisms and test potential treatments, including studies of stem cell therapies themselves.
Publication output has remained fairly steady over the past decade, fluctuating between roughly 4 and 9 papers per year without a clear upward or downward trend.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- A highly efficient method to differentiate CGRP-expressing peptidergic nociceptors from human induced pluripotent stem cells
Stem Cell Reports · 2026
- A human endothelial and adipose stem cell-based co-culture model for venous malformations
Angiogenesis · 2026
- The inpatient cancer diagnostic service: An academic cancer center experience.
Journal of Clinical Oncology · 2026
- Impact of proton pump inhibitors on immunotherapy is modulated by prior chemotherapy and linked to gut microbiome–immune cell signatures
Cancer Immunology Immunotherapy · 2026
- Menstruation-induced vaso-occlusive crisis in women with sickle cell disease
Blood · 2025
- Microfluidic vessel-on-chip platform for investigation of cellular defects in venous malformations and responses to various shear stress and flow conditions
Lab on a Chip · 2025
- A human induced pluripotent stem cell toolbox for studying sex chromosome effects
Stem Cell Reports · 2025
- A human induced pluripotent stem cell toolbox for studying sex chromosome effects
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- VHL Gene Restoration Supports RCC Reprogramming to iPSCs but Does Not Ensure Line Stability
Cancers · 2025
- Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytes
Cell stem cell · 2024
- Human iPSC and CRISPR targeted gene knock-in strategy for studying the somatic TIE2L914F mutation in endothelial cells
Angiogenesis · 2024
- Epigenetic regulation by polycomb repressive complex 1 promotes cerebral cavernous malformations
EMBO Molecular Medicine · 2024
- RYR2 deficient human model identifies calcium handling and metabolic dysfunction impacting pharmacological responses
Frontiers in Cardiovascular Medicine · 2024
- Cryopreserved apoptotic mesenchymal stromal cells retain functional efficacy in suppressing an allergic inflammation in a murine model
Stem Cells Translational Medicine · 2024
- Correction: Human iPSC and CRISPR targeted gene knock-in strategy for studying the somatic TIE2L914F mutation in endothelial cells
Angiogenesis · 2024
- Journal of the American Society of Nephrology×4
- Stem Cell Reports×3
- Angiogenesis×3
- Scientific Reports×3
- Stem Cell Research×2
- Xiaoping Bao
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Qi Zhou
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Mark E. Hester
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Ji‐Dong Fu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Wei Li
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile